Continuing connected transactions promotion cooperation agreement
Filed with HKEX · Stock code 6955 · · 8 pages · English
Summary by 6ix AI
The annual caps for fees payable under this agreement have been established, and the transactions are classified as continuing connected transactions under the Listing Rules. The company believes this collaboration will enhance market penetration and brand awareness for its biosimilar products, contributing to revenue growth.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Shandong Boan Biotechnology Company., Limited on 6ix
Earlier from Shandong Boan Biotechnology
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Interim report 2026
- Next Day Disclosure Return
- Voluntary announcement cde approval of IND application for BA1203 (a masked anti-PD-1/IL-2 fusion protein)
- Poll results of the annual general meeting held on 22 June 2026
Follow Shandong Boan Biotechnology into a list and get an email when it puts out news.
Follow Shandong Boan Biotechnology